Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
(RTTNews) - AbbVie (ABBV) announced that a new 6-month 45mg LUPRON DEPOT, or leuprolide acetate for extended-release injectable suspension, strength has received Health Canada approval for the ...
LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...
Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care. Following the 2025 European Society of Medical Oncology (ESMO) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results